We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

3bky

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px <!-- The line below this paragraph, containing "STRUCTURE_3bky", creates the "Structure Box" on the page. You may change the PDB parameter (which sets the PD...)
Line 1: Line 1:
-
[[Image:3bky.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:3bky.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_3bky| PDB=3bky | SCENE= }}
{{STRUCTURE_3bky| PDB=3bky | SCENE= }}
-
'''Crystal Structure of Chimeric Antibody C2H7 Fab in complex with a CD20 Peptide'''
+
===Crystal Structure of Chimeric Antibody C2H7 Fab in complex with a CD20 Peptide===
-
==Overview==
+
<!--
-
Anti-CD20 monoclonal antibodies have been proven to be efficient in the treatment of certain B-cell lymphomas and autoimmune diseases. Intriguingly, these antibodies seem to exert diverse functions with narrow epitope specificity. This study is to investigate the molecular basis of the fine specificity of 2H7 derived antibodies which are of great therapeutic potential. We show that chimeric 2H7 (C2H7) can mediate complement dependent cytotoxicity and antibody-dependent cellular cytotoxicity effects on CD20 positive human Burkitt lymphoma cells and the Fab fragment can well recognize and bind to an epitope peptide of the extracellular loop of CD20. The crystal structure of C2H7 in complex with the CD20 epitope peptide was determined at 2.6A resolution. The bound peptide displays a circular conformation and the binding specificity is mainly contributed by the (170)ANPS(173) motif and the disulfide bond of the peptide which maintains the unique conformation of the peptide. Compared with the complex structure of another anti-CD20 monoclonal antibody Rituximab with the same epitope peptide which was previously determined, the major differences lie in the CDR loop H3 of C2H7 which stretches outward against the interface. Correspondingly, the pocket which accommodates the peptide becomes wider and the peptide moves toward loop H3 and thus is more distant from loops H1 and H2. The hydrogen-bonding interactions are also quite different from those observed in the Rituximab-epitope peptide complex, and both the hydrophilic and hydrophobic interactions are less intense. Our data not only reveal the molecular basis for the fine specificity of C2H7 to CD20, but also provide valuable information for further improvement of antibodies derived from 2H7.
+
The line below this paragraph, {{ABSTRACT_PUBMED_18346788}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 18346788 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_18346788}}
==About this Structure==
==About this Structure==
Line 37: Line 41:
[[Category: Phosphoprotein]]
[[Category: Phosphoprotein]]
[[Category: Transmembrane]]
[[Category: Transmembrane]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Apr 30 13:32:57 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 15:30:47 2008''

Revision as of 12:30, 29 July 2008

Image:3bky.png

Template:STRUCTURE 3bky

Crystal Structure of Chimeric Antibody C2H7 Fab in complex with a CD20 Peptide

Template:ABSTRACT PUBMED 18346788

About this Structure

3BKY is a Protein complex structure of sequences from Homo sapiens, mus musculus. Full crystallographic information is available from OCA.

Reference

Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptide., Du J, Wang H, Zhong C, Peng B, Zhang M, Li B, Hou S, Guo Y, Ding J, Mol Immunol. 2008 May;45(10):2861-2868. Epub 2008 Mar 17. PMID:18346788

Page seeded by OCA on Tue Jul 29 15:30:47 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3bky"
Personal tools